2023
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians
Di Paola A, Farabee D, Springer S. Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians. Psychiatric Research And Clinical Practice 2023, 5: 78-83. PMID: 37711754, PMCID: PMC10499189, DOI: 10.1176/appi.prcp.20230022.Peer-Reviewed Original ResearchStimulant use disorderUse disordersSevere opioid use disorderMini International Neuropsychiatric InterviewDiagnostic assessmentOpioid use disorderDisorder assessmentInternational Neuropsychiatric InterviewDSM-IV criteriaHarm reduction interventionsNon-clinical staffTraditional diagnostic assessmentInternal consistencyDSM-5 versionValid measureOpioid dependenceOpioid misuseImmediate treatmentNeuropsychiatric InterviewOpioid epidemicDisorder modulesOverdose deathsReduction interventionsNon cliniciansRapid diagnosis
2016
Do they see dead people? Cultural factors and sensitivity in screening for schizophrenia spectrum disorders
Peltier MR, Cosgrove SJ, Ohayagha K, Crapanzano KA, Jones GN. Do they see dead people? Cultural factors and sensitivity in screening for schizophrenia spectrum disorders. Ethnicity And Health 2016, 22: 119-129. PMID: 27306965, DOI: 10.1080/13557858.2016.1196650.Peer-Reviewed Original ResearchConceptsSchizophrenia spectrum disordersAA patientsVisual hallucinationsMini International Neuropsychiatric InterviewHIV outpatient clinicInternational Neuropsychiatric InterviewAfrican AmericansOutpatient clinicNeuropsychiatric InterviewSubsequent diagnosisDisorder modulesSpectrum disorderPsychotic disordersScreening interviewAuditory hallucinationsCurrent studySymptom presentationLogistic regressionPatientsHallucinationsDisordersClinicUnusual experiencesCliniciansDiagnosis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply